Hennion & Walsh Asset Management, Inc. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$981,668
+127721.4%
22,536
+6.0%
0.06%
+37.0%
Q2 2023$768
-3.0%
21,252
-0.2%
0.05%
-6.1%
Q1 2023$792
-11.5%
21,299
+7.8%
0.05%
-10.9%
Q4 2022$895
-99.9%
19,763
+111.9%
0.06%
+27.9%
Q3 2022$651,000
+38.5%
9,327
+33.2%
0.04%
+48.3%
Q2 2022$470,000
-68.7%
7,001
-17.4%
0.03%
-63.3%
Q3 2021$1,500,000
-17.5%
8,478
-24.7%
0.08%
-18.6%
Q2 2021$1,819,000
-58.2%
11,260
-55.7%
0.10%
-62.8%
Q1 2021$4,350,00025,3940.26%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders